News Digest / Ticker: KTTA

Ticker: KTTA

04:05pm, Thursday, Aug 14, 2025

Pasithea advances PAS-004 in Phase 1 but burning cash; Nasdaq bid-price notice looms

Pasithea Therapeutics Corp. (NASDAQ: KTTA) - Quick read One-line summary: Clinical-stage biotech advancing PAS-004 through multiple Phase 1 programs while burning cash; recent financing improved cash but company remains dependent on additional capital and faces a Nasdaq minimum bid-price notice. ...